# Orion Holdings

> Orion Holdings is a VC fund in Yongsan backing Biotechnology, Banking and Finance. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Yongsan, South Korea
- Total investments: 3
- Last investment: Dec 2025
- Lead investor: 67%
- Last updated: Aug 2026
- Website: http://www.oriongroup.co.kr

Orion Holdings is a food manufacturing company.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Banking | 1 | 33% |
| Finance | 1 | 33% |
| Medical | 1 | 33% |
| Oncology | 1 | 33% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Private Equity | 1 | 33% |
| Post-IPO Equity | 1 | 33% |
| Venture - Series Unknown | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 2 | 67% |
| Italy | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Credito Lombardo Veneto | Credito Lombardo Venetois a commercial bank that provides debt facilities such as loans, revolving credit lines, bonds, and unsecured debts. |  | Venture - Series Unknown | Dec 17, 2025 |  |
| LegoChem Biosciences | Lego Chem Bioscience , a company created by people with dreams and enthusiasm for global new drug development, will open up new horizons in Korean new drug development based on systematic drug development system and core technology. | $416.5M | Post-IPO Equity | Jan 15, 2024 |  |
| Quratis | Quratis is a biopharmaceutical company specializing in the development of vaccines and therapeutic agents for infectious diseases. Its lead product, QTP101, is a subunit tuberculosis vaccine designed as a BCG booster for adolescents and adults, currently undergoing clinical trials. The company is also developing QTP104, a self-replicating mRNACOVID-19 vaccine, in collaboration with HDT Bio. | $36.9M | Private Equity | Sep 06, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [Banco Di Desio E Della Brianza S.P.A.](https://shizune.co/investors/profile/banco-di-desio-e-della-brianza-s-p-a) — VC Fund, 1 deal together
- First Capital — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Foresight Group](https://shizune.co/investors/profile/foresight-group) — VC Fund
- [YFM Equity Partners](https://shizune.co/investors/profile/yfm-equity-partners) — VC Fund
- [Fondaction](https://shizune.co/investors/profile/fondaction) — VC Fund

## FAQ

### What does Orion Holdings invest in?

Orion Holdings invests primarily in Biotechnology, Banking and Finance startups, most often at Private Equity and Post-IPO Equity stage. Most of the 3 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Orion Holdings last invest?

The most recent investment recorded for Orion Holdings closed in Dec 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co